semaglutide news october 16 2025 Trump says price of Ozempic will be lowered State tying weight loss drug

Contrave: Nausea, constipation, headache, insomnia Increased blood pressure and heart rate Other effects: anxiety, dizziness, dry mouth, tremors, risk of seizures in susceptible individuals Serious risks: liver problems, severe allergic reactions, neuropsychiatric events, including mood changes or suicidal thoughts Wegovy: Gastrointestinal issues: nausea, vomiting, diarrhea, constipation, abdominal pain Other effects: fatigue, headache, dizziness (especially during dose escalation) Serious risks: pancreatitis, gallbladder disease, thyroid tumors in high-risk patients, increased heart rate Important: Neither medication is a cure for obesity

Therefore, the same drug can move from covered to denied based on documentation alone

The second is that the study looked exclusively at people with diabetes, as theyre at a higher risk of developing mental health disorders making it unclear if these potential benefits would apply to people taking GLP-1s for other reasons

Because of this, obesity is seen as a chronic medical condition that often needs medical help and behavioral support, not just a new diet

It is about strategically rebuilding satiety and satisfaction so hunger does not dominate your decisions again. Physical activity is medicine

Its classified as a dual GIP/GLP-1 agonist that has been shown to have stronger effects [22] on controlling blood sugar and promoting weight loss